Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

The Regents of the University of California||UC Davis Health, Rancho Cordova, California, United States

UC Davis Health, Sacramento, California, United States

UC Davis Ambulatory Care Clinic, Sacramento, California, United States

UC Davis Hemophilia Treatment Center, Sacramento, California, United States

UC Davis Medical Center, Sacramento, California, United States

UCSF Outpatient Hematology Clinic, San Francisco, California, United States

USF Health Morsani Center For Advanced Healthcare, Tampa, Florida, United States

The University of South Florida Board of Trustees, Tampa, Florida, United States

Mississippi Center For Advanced Medicine, Madison, Mississippi, United States

Cornell University||Joan & Sanford I. Weill Medical College, New York, New York, United States

Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, United States

The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia, Pennsylvania, United States

The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia, Pennsylvania, United States

Washington Institute for Coagulation, Seattle, Washington, United States

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Sydney Local Health District (RPAH Zone), Camperdown, New South Wales, Australia

Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada

Kyung Hee University Hospital at Gangdong, Seoul, South Korea

Skåne University Hospital, Malmö, Sweden

Taichung Veterans General Hospital, Taichung, Taiwan

National Taiwan University Hospital, Taipei, Taiwan

Ege Universitesi Hastanesi, Izmir, İ̇zmir, Turkey (Türkiye)

Acibadem Adana Hospital, Adana, Turkey (Türkiye)